<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Aditya Birla Capital Limited

NSE: ABCAPITAL · Lot size: 3100

Aditya Birla Capital Limited Open Interest & PCR Analysis

344.75Updated 21 Apr 2026, 01:26 pm IST
PCR
0.69
Bearish signal
Max Pain
330
Spot above by ₹15
Total CE OI
13.00M
Call writers
Total PE OI
8.97M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Aditya Birla Capital Limited PCR (Put-Call Ratio) today?
Aditya Birla Capital Limited's current PCR is 0.69. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Aditya Birla Capital Limited's PCR of 0.69 indicates bearish sentiment.
What is Aditya Birla Capital Limited OI buildup type today?
Aditya Birla Capital Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Aditya Birla Capital Limited?
Aditya Birla Capital Limited has total CE (call) OI of 13001400 contracts and total PE (put) OI of 8971400 contracts for the nearest expiry. The PCR is 0.69.
How is open interest analysis useful for Aditya Birla Capital Limited trading?
OI analysis for Aditya Birla Capital Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Aditya Birla Capital Limited?
Aditya Birla Capital Limited's max pain is ₹330 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.